Sale of a Primary Sublicensor. Company understands and agrees that the owners of each of mRNA RiboTherapeutics and Cellscript shall have the right to sell all or any part of the outstanding stock or ownership interest or the business or the assets thereof, as applicable, of mRNA RiboTherapeutics and/or Cellscript [***] at any time and without any conditions pursuant to this Agreement other than the requirements under Section 15.5, except that, as a condition to any such sale occurring prior to [***]:
Appears in 3 contracts
Samples: Patent Sublicense Agreement (Moderna, Inc.), Patent Sublicense Agreement (Moderna, Inc.), Patent Sublicense Agreement (Moderna, Inc.)
Sale of a Primary Sublicensor. Company understands and agrees that the owners of each of mRNA RiboTherapeutics and Cellscript shall have the right to sell all or any part of the outstanding stock or ownership interest or the business or the assets thereof, as applicable, of mRNA RiboTherapeutics and/or Cellscript and/or any of their respective affiliates that [***] at any time and without any conditions pursuant to this Agreement other than the requirements under Section 15.5, except that, as a condition to any such sale occurring prior to [***]April 1, 2020:
Appears in 3 contracts
Samples: Patent Sublicense Agreement, Patent Sublicense Agreement (BioNTech SE), Patent Sublicense Agreement (BioNTech SE)
Sale of a Primary Sublicensor. Company understands and agrees that the owners of each of mRNA RiboTherapeutics and Cellscript shall have the right to sell all or any part of the outstanding stock or ownership interest or the business or the assets thereof, as applicable, of mRNA RiboTherapeutics and/or Cellscript and/or any of their respective affiliates [***] at any time and without any conditions pursuant to this Agreement other than the requirements under Section 15.5, except that, as a condition to any such sale occurring prior to [***]April 1, 2020:
Appears in 2 contracts
Samples: Patent Sublicense Agreement (BioNTech SE), Patent Sublicense Agreement (BioNTech SE)
